Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cardiovascular effects of sub-daily levels of ambient fine particles: a systematic review

  • Omar Burgan1,
  • Audrey Smargiassi1, 2Email author,
  • Stéphane Perron3 and
  • Tom Kosatsky4
Environmental Health20109:26

DOI: 10.1186/1476-069X-9-26

Received: 7 February 2010

Accepted: 15 June 2010

Published: 15 June 2010

Abstract

Background

While the effects of daily fine particulate exposure (PM) have been well reviewed, the epidemiological and physiological evidence of cardiovascular effects associated to sub-daily exposures has not. We performed a theoretical model-driven systematic non-meta-analytical literature review to document the association between PM sub-daily exposures (≤6 hours) and arrhythmia, ischemia and myocardial infarction (MI) as well as the likely mechanisms by which sub-daily PM exposures might induce these acute cardiovascular effects. This review was motivated by the assessment of the risk of exposure to elevated sub-daily levels of PM during fireworks displays.

Methods

Medline and Elsevier's EMBase were consulted for the years 1996-2008. Search keywords covered potential cardiovascular effects, the pollutant of interest and the short duration of the exposure. Only epidemiological and experimental studies of adult humans (age > 18 yrs) published in English were reviewed. Information on design, population and PM exposure characteristics, and presence of an association with selected cardiovascular effects or physiological assessments was extracted from retrieved articles.

Results

Of 231 articles identified, 49 were reviewed. Of these, 17 addressed the relationship between sub-daily exposures to PM and cardiovascular effects: five assessed ST-segment depression indicating ischemia, eight assessed arrhythmia or fibrillation and five considered MI. Epidemiologic studies suggest that exposure to sub-daily levels of PM is associated with MI and ischemic events in the elderly. Epidemiological studies of sub-daily exposures suggest a plausible biological mechanism involving the autonomic nervous system while experimental studies suggest that vasomotor dysfunction may also relate to the occurrence of MI and ischemic events.

Conclusions

Future studies should clarify associations between cardiovascular effects of sub-daily PM exposure with PM size fraction and concurrent gaseous pollutant exposures. Experimental studies appear more promising for elucidating the physiological mechanisms, time courses and causes than epidemiological studies which employ central pollution monitors for measuring effects and for assessing their time course. Although further studies are needed to strengthen the evidence, given that exposure to sub-daily high levels of PM (for a few hours) is frequent and given the suggestive evidence that sub-daily PM exposures are associated with the occurrence of cardiovascular effects, we recommend that persons with cardiovascular diseases avoid such situations.

Background

Exposure to higher than usual levels of ambient particulate air pollution over the course of several hours to several days has been shown to contribute to acute cardiovascular events such as arrhythmia, ischemia and myocardial infarction, which all could lead to emergency department visits, hospitalisation and death [13].

Various physiological pathways have been proposed to explain such cardiovascular effects. As presented in figure 1, likely mechanisms by which sub-daily levels of fine particles (PM) induce acute cardiovascular effects may involve the autonomic nervous system, systemic inflammation, vasomotor dysfunction and/or thrombogenesis [13].
Figure 1

Likely mechanisms whereby sub-daily exposures of fine particles (PM) induce acute cardiovascular effects (arrhythmia, ischemia and infarction). Adapted from Brook et al. [1] and Mills et al [3].

While acute effects appear to occur soon after exposure to ambient PM [2], only recently have studies addressed whether cardiovascular events and exacerbations of respiratory disease symptoms associated with exposure to ambient PM relate mainly to brief (minutes or hourly) high-level exposure of particles or if they result from exposure averaged over an entire day. As such, sub-daily levels of PM are not regulated as is the case with other air pollutants for which sub-daily standards have been set (e.g. 1 h standard for ozone). Furthermore, guidance for vulnerable persons faced with high sub-daily exposure situations is lacking even if such exposures occur in many real-life situations such as in traffic jams, at bus stops, during accidental fires and explosions, in arenas, in indoor parking garages, during fireworks displays, etc.

Much of our understanding of the epidemiology of short-term ambient PM exposure derives from the linkage of administrative records of population health data with air pollution levels obtained from fixed site ambient monitors. Given that the precise timing of death, hospital admissions, and emergency room visits, are rarely available in administrative databases, epidemiological assessments based on such databases have not adequately addressed the effects of sub-daily high-level ambient particulate exposures.

We conducted a theoretical model-driven non-meta-analytic systematic literature review of published studies performed in humans, with the objective of providing a comprehensive evaluation of the cardiovascular effects of sub-daily exposures (≤6 hours) to ambient PM. A model-driven synthesis is a review that incorporates a conceptual model (see figure 1) and that attempts to provide information about the set of relationships among constructs of variables [4]. We chose this approach in an attempt to delineate information gaps meriting further research with regards to the likely mechanisms whereby sub-daily exposures to PM may induce acute cardiovascular effects. The model was used to define the keywords and, to organise and analyse the existing research.

The main questions addressed by this review are: 1) Does short duration exposure (sub-daily) to PM induce cardiovascular effects such as arrhythmia, ischemia and infarction?; 2) Do cardiovascular effects following short duration exposure to PM occur quickly after exposure?; 3) What are the likely mechanisms whereby sub-daily exposures to PM may induce acute cardiovascular effects such as arrhythmia, ischemia and infarction?

Methods

Data Sources

The bibliographic databases consulted were Medline and Elsevier's EMBase, using the Ovid portal. The temporal limits used were January 1996 to December 2008. Our search started in 1996 as no information was yet published on the subject before 1996, according to the 2004 U.S. Environmental Protection Agency Air quality criteria document for particulate matter [2].

Data Extraction

The search strategy consisted of a combination of descriptors representing 1) cardiovascular effects (e.g. myocardial infarction), 2) the pollutant of interest (e.g. ambient PM) and, 3) the short duration of the exposure (e.g. short-term, peaks). The limits defined the age groups in which the study was performed (adults, age ≥ 18 years) and the language in which the study was published (English).

Only peer-reviewed scientific articles were retrieved. They were then selected by hand according to the following exclusion criteria: occupational studies; studies where exposure was to tobacco smoke, studies performed in animals, studies where there was no exposure to PM or studies where neither myocardial infarction (MI), arrhythmia, ischemia, nor vasomotor tone, thrombogenesis or heart rate and rhythm were measured. Commentaries, opinion and review articles were not analysed and neither were studies where exposure was for durations greater than 6 hours. Furthermore, only one publication of the same study/database was considered. The references cited in the selected articles were then searched to ensure completeness of the information gathered.

Data Synthesis Method

Selected studies were organised into groups addressing specific sets of relationships among the construct of variables, presented in Figure 1. This figure was based on two important reviews by Brook et al. [1] and Mills et al. [3]. The following information was extracted from each article: design (human experimental or epidemiological studies), population characteristics (age and the presence of pre-existing cardiovascular disease; the latter were assumed to be on medication), particulate exposure characteristics (mass and number concentrations of particles with median diameters smaller than 10 μm, elemental and organic carbon levels and, duration and lags used) as well as presence of an association with the following health effects or physiological assessments: ST-segment depression, cardiac arrhythmia, MI, vasoconstriction assessed with blood pressure measurement, brachial artery diameter (BAD), flow mediated dilation (FMD) or forearm blood flow (FBF), changes in the standard deviation of all the normal-to-normal intervals (SDNN) on electrocardiogram and increased coagulation assessed with fibrinogen, platelet or tissue-plasminogen activator (t-PA) antigen levels. ST-segment depression (as a proxy for ischemia), arrhythmia and MI were considered as health effects; the other physiological assessments were analysed as measurements made to clarify mechanisms whereby sub-daily exposures to PM induce acute cardiovascular effects.

In the selected articles assessing the association between exposure to sub-daily levels of PM and heart rate variability measures, both time and frequency domains have been assessed but for simplification, here we only report on SDNN. Furthermore, blood markers of coagulation other than fibrinogen, platelets and t-PA were identified in the literature but as they were not consistently measured in many studies, they were not considered in our analysis. Moreover, associations with pollutants other than to particulate matter are not reported in the present study. When studies reported on the effects of both sub-daily and daily exposure to PM, we only reported the effects of sub-daily exposure as we did not review all studies where exposure to PM was longer than 6 hours in duration (including 24 hour studies) and only in a minority of studies that we reviewed were both hourly and daily exposure durations reported.

For our assessment of the literature, we defined a lag as the difference in hours between the end of the exposure and a physiological assessment or a health effect. For example, if MI occurred at 17 h00 and an exposure to PM at 14 h00 to 16 h00 is being considered, then the lag is 1 h and the duration of exposure is 2 h. In some instances, particularly in experimental studies, lag0 also included assessments made during the exposure. We report results for all lags assessed but again only results where exposure duration was 6 hours or less. We identified the presence of an association based on statistical significance. We did not perform a meta-analysis of available studies. A meta-analytic review that examines the magnitude of effects at different lags, for different outcome and PM size, is beyond the scope of this article. The objective of our comprehensive review was to assess whether acute effects of sub-daily PM exposures have been reported. The method used to quantitatively assess the evidence for each set of relationships was limited to vote-counting of statistically significant associations [5]. An association was considered 'suggestive' if more than half of the studies measuring the same effect showed an association in the same direction. If there were associations in fewer than half of the studies or, if the results were contradictory, we considered that there was limited evidence.

Results

Description of studies

Figure 2 presents a flow chart of the stages of the selection of the studies for analysis. The initial key word search yielded 235 articles but four articles were excluded to retain only one article per study. Applying the above mentioned inclusion/exclusion criteria left 47 articles. To these 47 articles in which the duration of exposure was under or equal to 6 hours, five more articles were obtained from reference snowballing, for a total of 52 articles reviewed.
Figure 2

Progress through the stages of the selection of studies for analysis.

The information retrieved from 49 of the 52 studies is organised into four tables (Table 1, Table 2, Table 3 and Table 4) addressing the following sets of relationships with sub-daily exposures to PM that can be derived from Figure 1: i) cardiovascular effects (n = 17): five studies assessed ST-segment depression [610] which most likely indicated ischemia, eight studies arrhythmia or fibrillation [9, 1117] and, five studies were on MI [1822]; ii) heart rate variability (SDNN): n = 20 [1517, 2339]; iii) vasoconstriction: n = 17 [9, 10, 1517, 36, 38, 4049]; iv) coagulation: n = 15 [9, 10, 15, 17, 36, 38, 39, 43, 44, 48, 5054]. The remaining three studies [5557] were excluded as they did not report on the presence of an association with the health effects or physiological assessments presented in Table 1, Table 2, Table 3 and Table 4 which were selected for analysis. While table 1 groups studies examining cardiovascular effects, Table 2, Table 3 and Table 4 group those addressing likely mechanisms by which sub-daily PM exposure cause cardiovascular effects.
Table 1

Evidence of association between sub-daily exposure to PM and arrhythmia, ischemia and myocardial infarctiona

Authors

Subjects

Design

Exposure Levels

Dur.

Lags

Effect

ST-Segment depression

Chuang et al., 2008

Aged 43-75 yrs, with CVD

Epi.

Fixed site PM2.5 mean daily levels: 50th: 9 μg/m3, (max 40); BC measured;

1 to 6 hb

Lag0

-

Gold et al., 2005

Aged 61-88 yrs

Epi.

Fixed site PM2.5, 12 h mean levels: 10th: 4, 90th: 26 μg/m3; BC also measured;

1 hb

Lag1 to 12 h

↑ at lag1 to 12 with BC

Lanki et al., 2008

Mean age 68 yrs (SD7), with CVD

Epi. Assessment during exercise

Fixed site PM2.5 hrly levels: 25th: 9, 75th: 18 μg/m3; fixed site UFP also measured; personal measurements made;

1 and 4 hb

Lag0 to 24 h;

↑ at lag1 to 10 with PM2.5 1 h; ↑ with 4 h dur. pre-testing

Gong et al., 2003

Aged 18-45 yrs, 50% asthmatics

Exp.

CAP~PM2.5 : 174 μg/m3 (SD37) with exercise;

2 h

Lag0_4c 4_22 h

-

Mills et al., 2007b

Mean age 60 yrs (SD1), with prior MI

Exp.

Diesel PM : 300 μg/m3 with exercise;

1 h

Lag0

↑ at lag0

Fibrillation -arrhythmia

Ljungman et al., 2008

Mean age 62 yrs (SD13), with ICD

Epi.

Fixed site PM10 mean 2 h levels: 2 cities 50th: 19-15 μg/m3; PM2.5 measured in one city;

2 hb

Lag0

↑ v. arrhythmia with PM10; - with PM2.5

Rich et al., 2006

Aged 45-78 yrs, with ICD

Epi.

Fixed site PM2.5 hrly 50th: 9 μg/m3 (25th: 6, 75th: 15); BC also measured;

1 hb

Lag0

- a. fibrillation

Rich et al., 2006b

Mean age 63 yrs (20-88), with ICD

Epi.

Fixed site PM2.5 hrly 50th: 16 μg/m3 (25th: 12, 75th: 22); BC and OC also measured;

6 h

Lag0

- v. arrhythmia

Rich et al., 2005

Mean age 64 yrs (19-90), with ICD

Epi.

Fixed site PM2.5 hrly 50th: 9 μg/m3 (25th: 16, 75th: 15); BC also measured;

2 and 6 hb

Lag0

- v. arrhythmia

Gong et al., 2008

Aged 18-50 yrs, 45% asthmatics

Exp.

CAP~UFP : 100 μg/m3 (SD68) with exercise;

2 h

Lag0_4c 4_22 h

- ectopic beats

Gong et al., 2004

Mean age 36 yrs (SD11), 75% asthmatics

Exp.

CAP~PM10 : 157 μg/m3 (SD41) with exercise;

2 h

Lag0_4c 4_22 h

- ectopic beats

Gong et al., 2004b

Aged 54-85 yrs, 68% COPD

Exp.

CAP~PM2.5 : 167 (SD27) μg/m3; with exercise;

2 h

Lag0_4c 4_22 h

- ectopic beatsd

Gong et al., 2003

Aged 18-45 yrs, 50% asthmatics

Exp.

CAP~PM2.5 : 174 μg/m3 (SD37) with exercise;

2 h

Lag0_4c 4_22 h

- ectopic beats

Myocardial Infarction and cardiac arrest

Murakami et al., 2006

Deaths for MI, mean age 72 yrs (SD13)

Epi.

Fixed site PM7 hrly 50th: 44 μg/m3 (0-1093);

1 to 6hb

Lag0

Peters et al., 2005

MI subjects, mean age 60 yrs (25-74)

Epi.

Fixed site PM2.5 hrly 50th: 15 μg/m3 (25th: 11, 75th: 20); UFP also measured; Exposure to traffic;

1 hb

Lag0 to 6 h and 24 h

- with PM2.5 or UFP; ↑ with traffic at lag0 to 6 h

Peters et al., 2001

MI subjects, mean age 62 yrs (SD13)

Epi.

Fixed site PM2.5 hrly mean: 12 μg/m3 (SD9);

1 hb

Lag0 to 5 h and 24 h

↑ at lag0 to 2 h

Rosenthal et al., 2008

Cardiac arrest subjects, mean age 61 yrs (SD17)

Epi.

Fixed site PM2.5 hrly 50th: 14 μg/m3 (10th: 6, 90th: 30);

1 and 4 hb

Lag0 to 8 h

↑ at lag0 and 1 h

Sullivan et al., 2005

MI subjects, mean age 69 yrs (21-98)

Epi.

Fixed site PM2.5 hrly 50th: 8.6 μg/m3 (2-147);

1, 2, 4 hb

Lag0

-

a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied; c Lag0_4 includes up to 90 minutes before the beginning of exposure; d Inconsistent results were reported between population subgroups (e.g. normal and asthmatics);

Abbreviations: a. fibrillation: Atrial fibrillation; BC: Black carbon; CAP: Concentrated ambient particles; CVD: Cardiovascular disease; COPD: Chronic obstructive pulmonary disease; Dur.: Duration of exposure; Epi.: Epidemiological; Exp.: Experimental; hrly: Hourly; ICD: Implantable cardioverter defibrillators; MI: Myocardial infarction; OC organic carbon; PM: Fine particles; SD: Standard deviation; UFP: Ultrafine particles; v. arrhythmia: Ventricular arrhythmia; -: No significant statistical association;

Table 2

Evidence of association between sub-daily exposure to PM and SDNNa

Authors

Subjects

Design

Exposure Levels

Dur.

Lags

SDNN

Adar et al., 2007

Aged 62-92 yrs, 82% HT

Epi.

PM2.5 mean on bus: 17 μg/m3 (SD10); BC also measured;

5', 30', 1, 4 hb

Lag0

↓ with PM2.5 and BC (more on bus (5' dur.)

Chang et al., 2007

Mean age 66 yrs (SD7), 47% CVD, 60% HT

Epi.

Mean personal PM2.5: 31 μg/m3 (SD27); Other PM size also measured;

1 to 6 hb

Lag0

↓ with PM2.5-10; ↑ with PM1-2.5

Chuang et al., 2007

Mean age 70 yrs (SD12), with or at risk of CVD

Epi.

Fixed site PM2.5 hrly mean: 52 μg/m3 (SD40); SO42- and OC also measured;

1 to 4 h

Lag0

↓ mostly with SO42-

Chuang et al. 2005

Mean age 68.1 yrs (SD3.6), 39% CVD, 61% HT

Epi.

Mean personal PM1-2.5: CVD:11 μg/m3 (SD9) and HT 13 (SD8);

1 to 4 h

Lag0

↓ with PM0.3-1; - with PM1-10

Gold et al., 2000

Mean age 73 yrs (53-87), 29% CVD, 57% HT

Epi.

Fixed site PM2.5, 4 h mean: 15 μg/m3 (3-49); PM10 also measured;

1 and 4 hb

Lag0

↓ with PM2.5

Lipsett et al., 2006

Mean age 71 yrs (SD6), with CVD

Epi.

Fixed site PM2.5 daily mean at 2 sites: 23 μg/m3 (6-90) and 14 (5-52); PM10 also measured;

2, 4, 6 hb

Lag0

↓ with PM10; - with PM2.5

Magari et al., 2002

Mean age 43 yrs (SD13)

Epi.

Daily mean personal PM2.5: 150 μg/m3 (SD292);

15'to 6 hb

Lag0

↓ up to 6 h dur.

Luttmann-Gibson et al., 2006

Mean age 71 yrs (54-90), 84% CVD

Epi.

Fixed site PM2.5 daily mean: 20 μg/m3 (25th: 12, 75th: 25); SO42- and elemental carbon (EC) also measured;

4 and 6 hb

Lag0

-

Sullivan et al., 2005b

Median age 77 yrs (57-87), 62% CVD

Epi.

Hrly mean outside home PM2.5: 11 μg/m3 (3-40);

1 and 4 hb

Lag0

-

Vallejo et al., 2006

Mean age 27 yrs (21-35)

Epi.

Median personal PM2.5: 74 μg/m3 (25th: 49, 75th: 111);

30' to 210'

Lag0

-

Wheeler et al., 2006

Aged 49-76 yrs, 46% CVD, 54% COPD

Epi.

Fixed site PM2.5, 4 h mean:: 18 μg/m3 (25th: 12, 75th: 22);

1 and 4 hb

Lag0

-

Beckett et al., 2005

Mean age 35 yrs (23-52)

Exp.

UFP and fine Zn PM: 500 μg/m3;

2 h

Lag0, 3, 6, 11, 23 h

-

Devlin et al., 2003

Mean age 67 yrs (SD1)

Exp.

CAP < PM2.5: 41 μg/m3 (SD9); with exercise;

2 h

Lag0 and 24 h

-

Frampton et al., 2004

Aged 18-40 yrs, 57% asthmatics

Exp.

UFP: 10 or 25 μg/m3; with exercise;

2 h

Lag0, 3.5, 15, 21, 45 h

-

Gong et al., 2008

Aged 18-50 yrs, 45% asthmatics

Exp.

CAP~UFP: 100 μg/m3 (SD68) for 2 h with exercise;

2 h

Lag0, 4, 22 h

-

Gong et al., 2004

Mean age 36 yrs (SD11), 75% asthmatics

Exp.

CAP~PM10 : 157 μg/m3 (SD41) with exercise;

2 h

Lag0, 4, 22 hc

-

Gong et al., 2004b

Aged 54-85 yrs, 68% COPD

Exp.

CAP~PM2.5 : 167 (SD27) μg/m3; with exercise;

2 h

Lag0, 4, 22 h

-

Peretz et al., 2008

Aged 24-48 yrs

Exp.

Diesel PM: 100 and 200 μg/m3 for 2 h;

2 h

Lag0, 1, 4, 20 h

-

Routledge et al., 2006

Aged 52-75 yrs, 50% CVD

Exp.

C UFP: 50 μg/m3;

1 h

Lag0 and 4 h

Scharrer et al., 2007

Mean age 29 yrs (SD8)

Exp.

Welding fume PM 50th: 3500 μg/m3 (1000-25300);

1 h

Lag 5 h

-

a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied;

Abbreviations: BC: Black carbon; C: Carbon; CAP: Concentrated ambient particles; COPD: Chronic obstructive pulmonary disease; CVD: Cardiovascular disease; Dur.: Duration of exposure; Epi.: Epidemiological; Exp.: Experimental; hrly: Hourly; HT: Hypertensive; OC Organic carbon; PM: Fine particles; SD: Standard deviation; SDNN: Standard deviation of all the normal-to-normal intervals; UFP: Ultrafine particles -: No significant statistical association;

Table 3

Evidence of association between sub-daily exposure to PM and vasoconstrictiona

Authors

Subjects

Design

Exposure Levels

Dur.

Lags

Vasocon- striction

Harrabi et al., 2006

Mean age 75 yrs (SD5), 46% HT, 6% MI

Epi.

Fixed site PM10 hrly mean: 20 μg/m3 (SD10); SO42- and OC also measured;

1 hb

Lag0, 3, 5, 24 h

↓SBP at lag3 and 5 h

Brook et al., 2002

Mean age 35 yrs (SD10)

Exp.

CAP~PM2.5: 153 μg/m3 (SD35) + O3;

2-2.5 h

Lag0

↓BAD; -BP and FMD

Dales et al., 2007

Aged 18-50 yrs

Exp.

PM2.5 bus stop 1: 40 μg/m3 (SD20); PM2.5 bus stop 2: 10 μg/m3 (SD10); PM1 also measured;

2 h

Lag0

↓FMD with PM2.5 not with PM1; -BP

Frampton et al., 2004

Aged 18-40 yrs, 57% asthmatics

Exp.

UFP: 10 or 25 μg/m3; with exercise;

2 h

Lag0, 3.5, 15, 21, 45 h

-BP

Gong et al., 2008

Aged 18-50 yrs, 45% asthmatics

Exp.

CAP~UFP: 100 μg/m3 (SD68) with exercise;

2 h

Lag0, 4, 22 h

-BP

Gong et al., 2004b

Aged 54-85 yrs, 68% COPD

Exp.

CAP~PM2.5 : 167 (SD27) μg/m3; with exercise;

2 h

Lag0, 4, 22 h

-BP

Gong et al., 2004

Mean age 36 yrs (SD11), 75% asthmatics

Exp.

CAP~PM10 : 157 μg/m3 (SD41) with exercise;

2 h

Lag0, 4, 22 h

-BP

Gong et al., 2003

Aged 18-45 yrs, 50% asthmatics

Exp.

CAP~PM2.5 : 174 μg/m3 (SD37) with exercise;

2 h

Lag0, 4, 22 h

-BPc

Mills et al., 2008

Mean age 54 yrs (SD2), 50% CVD

Exp.

CAP~PM2.5 : 190 μg/m3 (SD37); with exercise;

2 h

Lag6 to 8 h

-FBF with vasodil. or not; -BP

Mills et al., 2007b

Mean age 60 yrs (SD1), with prior MI

Exp.

Diesel PM : 300 μg/m3; with exercise;

1 h

Lag6 to 8 h

-FBF with vasodil. or not; -BP

Mills et al., 2005

Aged 20-38 yrs

Exp.

Diesel PM : 300 μg/m3; with exercise;

2 h

Lag2, 6, 24 h

↓FBF with vasodil.; -BP

Peretz et al., 2008b

Aged 20-48 yrs

Exp.

Diesel PM: 100 and 200 μg/m3;

2 h

Lag0 and 3 h

↓BAD; -FMD and BP

Routledge et al., 2006

Aged 52-75 yrs, 50% CVD

Exp.

C UFP: 50 μg/m3;

1 h

Lag0 and 4 h

-BP

Rundell et al., 2007

Mean age 21 yrs (SD2)

Exp.

Nb of PM1 near busy road: 144K/cm3 (SD59K); with exercise;

for 30'

Lag0

↓BAD and FMD

Shah et al., 2008

Aged 18-40 yrs

Exp.

C UFP: 50 μg/m3; with exercise;

2 h

Lag0, 3.5, 21, 45 h

↓FBF post ischemia at Lag3.5

Törnqvist et al., 2007

Mean age 26 yrs (18-38)

Exp.

Diesel PM: 300 μg/m3; with exercise;

1 h

Lag 24 h

↓FBF with vasodil. at lag24; -BP

Urch et al., 2005

Aged 18-50 yrs

Exp.

CAP~PM2.5: 147 μg/m3 (SD27) + O3;

2 h

Lag0

↑DBP

a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied; c Inconsistent results were reported between population subgroups (e.g. normal and asthmatics);

Abbreviations: BAD: Brachial artery diameter; BC: Black carbon; BP: Blood pressure; C: Carbon; CAP: Concentrated Ambient Particles; COPD: chronic obstructive pulmonary disease; DBP: diastolic BP; Dur.: Duration of exposure; Epi.: Epidemiological; Exp.: Experimental; FBF: forearm blood flow measured by plethysmography; FMD: Flow mediated diameter; HT: Hypertensive; hrly: Hourly; MI: Myocardial infarction; O3: Ozone; OC organic carbon; PM: Particulate matter; SD: Standard deviation; SBP: systolic BP; UFP: Ultrafine particles; vasodil.: Vasodilators; -: No significant statistical association;

Table 4

Evidence of association between sub-daily exposure to PM and coagulationa

Authors

Subjects

Design

Exposure Levels

Dur.

Lags

PL

F

t-PA Agc

Rückerl et al., 2007

Aged 51-76 yrs, with CVD

Epi.

Fixed site PM2.5 daily mean: 20 μg/m3 (SD15); UFP nb, PM10 also measured;

6 hb

Lag0, 6, 12, 18 h

↓ with UFP lag 0 and 18 h

  

Carlsten et al., 2007

Mean age 25 yrs (21-43)

Exp.

Diesel PM: 100 and 200 μg/m3

2 h

Lag3, 6, 22 h

-

  

Frampton et al., 2004

Aged 18-40 yrs, 57% asthmatics

Exp.

UFP: 10 or 25 μg/m3; with exercise;

2 h

Lag0, 3.5, 15, 21, 45 h

-

-

 

Ghio et al., 2000

Mean age 26 yrs (SD1)

Exp.

CAP~PM2.5: 23-311 μg/m3; with exercise;

2 h

Lag18 h

-

 

Gong et al., 2008

Aged 18-50 yrs, 45% asthmatics

Exp.

CAP~UFP: 100 μg/m3 (SD68); with exercise;

2 h

Lag0, 4, 22 h

-

-

-

Gong et al., 2004b

Aged 54-85 yrs, 68% COPD

Exp.

CAP~PM2.5 : 167 (SD27) μg/m3; with exercise;

2 h

Lag0, 4, 22 h

-

-

 

Gong et al., 2003

Aged 18-45 yrs, 50% asthmatics

Exp.

CAP~PM2.5 : 174 μg/m3 (SD37); with exercise;

2 h

Lag0, 4, 22 h

-

-

 

Lucking et al., 2008

Aged 21-44 yrs

Exp.

Diesel PM: 350 μg/m3;

2 h

Lag2 and 6 h

-

  

Mills et al., 2008

Mean age 54 yrs (SD2), 50% CVD

Exp.

CAP~PM2.5 : 190 μg/m3 (SD37); with exercise;

2 h

Lag2, 6, 8 h

↑ at lag2

 

-

Mills et al., 2007b

Mean age 60 yrs (SD1), with prior MI

Exp.

Diesel PM: 300 μg/m3; with exercise;

1 h

Lag6, 24 h

  

↓ at lag6

Mills et al., 2005

Aged 20-38 yrs

Exp.

Diesel PM: 300 μg/m3; with exercise;

1 h

Lag2, 6, 24 h

-

 

↓ at lag6

Routledge et al., 2006

Aged 52-75 yrs, 50% CVD

Exp.

C UFP: 50 μg/m3;

1 h

Lag4 and 24 h

-

-

 

Salvi et al. 1999

Aged 21-28 yrs

Exp.

Diesel PM: 300 μg/m3; with exercise;

1 h

Lag 6 h

  

Scharrer et al., 2007

Mean age 29 yrs (SD8)

Exp.

Welding fume PM 50th: 3500 μg/m3 (1000-25300);

1 h

Lag 5 h

 

-

 

Törnqvist et al., 2007

Mean age 26 yrs (18-38)

Exp.

Diesel PM: 300 μg/m3; with exercise;

1 h

Lag 24 h

-

 

-

a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied; c Except in Gong et al., 2008, t-PA antigen was measured following infusion of vasodilators;

Abbreviations: Ag: Antigen; C: Carbon; CAP: Concentrated Ambient Particles; CVD: Cardiovascular disease; COPD: chronic obstructive pulmonary disease; Dur.: Duration of exposure; Epi.: Epidemiological; Exp.: Experimental; F: Fibrinogen; MI: Myocardial infarction; PL: platelets; nb: number; PM: Particulate matter; SD: Standard deviation; t-PA Ag: tissue plasminogen activator antigen; UFP: Ultrafine particles; -: No significant statistical association;

In total, 25 studies were epidemiological assessments; most of these studies used a longitudinal design. Levels of exposure to ambient particles in the epidemiological studies were in the range of those observed today in major American and European cities: The epidemiological studies usually reported hourly or daily mean or median PM2.5 levels (PM with median diameter < 2.5 μm) at fixed monitoring sites below 20 μg/m3. Exposure levels in the experimental studies typically ranged between 100 to 300 μg/m3 for one to two hours, which is a high daily maximum value in epidemiological studies performed in American and European cities. Particulate exposure characteristics varied between studies and included different particulate size fractions from fixed sites and personal measurements for epidemiological studies. Most experimental studies, on the other hand, used either concentrated ambient particles (CAP) or diesel exhaust to expose volunteers. Furthermore, exposure usually occurred with intermittent periods of exercise. Studies included both young and elderly people, healthy or with cardio-respiratory conditions and participants under medication.

Cardiovascular effects of sub-daily exposures to fine particles

According to our assessment of studies presented in Table 1, there is suggestive electrographic evidence that sub-daily exposures to PM decrease the ST-segment which most likely indicates ischemia of the myocardium: of five studies (two experimental) that assessed ST-segment depression during exercise, three found increased depression during and shortly after exposure. The experimental study which did not observe any effects exposed subjects aged < 50 years with no preexisting cardiovascular disease [9]. There are insufficient studies published to date to assess the effects of lags and duration of exposure. However, the experimental positive study by Mills et al. [10] suggests that ischemia during exercise can occur quickly after the start of exposure and that reversal of ischemia may occur within less than an hour of continued exposure.

As for fibrillation or arrhythmia, there is limited epidemiological evidence of effects of sub-daily exposures to PM in studies assessing patients with implantable defibrillators (n = 4) (Table 1): only one of four studies reported a positive association with sub-daily levels of PM. Studies performed by Gong et al, did not show association between sub-daily levels of PM and ectopic beats.

There is suggestive evidence that sub-daily exposures to PM induce MI (Table 1): while there are a limited number of studies addressing the issue, positive associations were found in four out of five epidemiological studies performed in older adults (mean age around 60 years); however there is insufficient information to assess if effects occur shortly after exposure or if effects become more pronounced as elapsed time since exposure increases.

Mechanisms whereby sub-daily exposures to fine particles may induce cardiovascular effects

The involvement of the autonomic nervous system has been suggested as a potential mechanism whereby sub-daily levels of PM may induce cardiovascular effects. In our assessment of studies that measured heart rate variability (presented in Table 2), discrepancies in results were noted between epidemiological (n = 11) and experimental studies (n = 9): while most epidemiological studies showed a decrease in SDNN, experimental studies did not report any associations. Contrary to epidemiological studies, most experimental studies did not assess the association in people with pre-existing cardiovascular disease. Furthermore, most studies assessed the effects of exposure at lag0 (the hour before the physiological assessment). As such, variations in SDNN appear to occur shortly after exposure; it is however impossible so far to assess whether variations in SDNN occur only shortly after exposure.

Regarding studies that assessed measurements of vasoconstriction (n = 15), which were mainly experimental in design, results were contradictory (Table 3): while blood pressure (BP) was mainly invariable, suggestive evidence of vasoconstriction was observed in studies where flow mediated dilation (FMD) or forearm blood flow (FBF) following vasodilator injection was measured. A positive association was found for short [46] as well as longer lags [48].

Finally, results of the 15 studies that assessed the effects of sub-daily levels of PM on fibrinolytic activity and coagulation were generally negative for change in the levels of platelets and fibrinogen (Table 4). Some discrepancies observed with levels of t-PA (a regulator of the degradation of intravascular fibrin) may be associated with the exposure conditions, as suggested by experimental studies performed by the same authors [10, 43, 44, 48]. According to these studies, it seems that diesel exposure would influence fibrinolytic activity [10, 44] but not concentrated ambient particles (CAP) [43]. Furthermore, this association would be observed at lag 6 h [10, 44] and not at lag 24 h [48].

Discussion

This literature assessment was performed to answer three main questions. First, do sub-daily exposures to PM induce cardiovascular effects such as arrhythmia, ischemia and MI? Our assessment shows that there is suggestive evidence that exposure to sub-daily levels of PM is associated with MI and ischemic events (mainly in the elderly and in individuals with prior cardiovascular diseases). There is limited evidence of an association between sub-daily levels of PM and arrhythmia or fibrillation; discrepancies observed may be due to methodological issues (see below). Our analysis was conducted without considering the effect of variable PM size. Further studies are needed to address the influence of PM size and composition on the acute cardiovascular effects of sub-daily exposure to PM as it may influence PM toxicity. Furthermore, meta-analytic reviews for each outcome should be performed to elucidate the magnitude of the observed associations.

Secondly, this review also addresses mechanistic issues. The delay with which cardiovascular effects appear following sub-daily exposure to PM was examined. Results of our analysis show that there is limited evidence suggesting that the cardiovascular effects of short duration exposure to PM occur quickly following exposure. However there is one experiment by Mills et al. [10] that demonstrates more pronounced myocardial ischemia during exercise which occurs minutes after the start of exposure. Further studies (experimental and epidemiological) are thus needed to confirm that cardiovascular effects of sub-daily exposure to PM may occur shortly, or with a short lag period, after the end of exposure. Furthermore, the reversal of ischemia observed in this study during exposure [10] suggests that in studies assessing the cardiovascular effects of PM, the timing of the health assessment should be carefully selected. Indeed, health effects may be missed due to the design of the study if the health assessment is not made at the right time (i.e. at the beginning of the exposure period).

Thirdly this review also addresses the physiological processes underlying whereby short exposures to PM, as opposed to longer averaging periods, may induce acute cardiovascular effects such as ischemia and myocardial infarction. According to the results of the studies reviewed, there is suggestive evidence from epidemiological studies that a plausible biological mechanism whereby sub-daily PM levels may induce effects involves the autonomic nervous system (as shown by studies on SDNN) even though experimental studies did not indicate this.

Discrepancies observed between epidemiological and experimental studies that measured SDNN may be due to differences in the number of repeated measures or to the fact that younger subjects without preexisting cardiovascular diseases were recruited in experimental studies. Experimental studies need to assess effects in those with pre-existing cardiovascular diseases to confirm associations observed in epidemiological studies between sub-daily PM exposure and SDNN. Similar associations with SDNN, as those reported here by epidemiological studies, have been observed in occupational studies [5860]. Occupational studies that we identified assessing the cardiovascular effects of exposure to sub-daily PM (not reviewed here) have mainly examined its association with heart rate variability. The involvement of the autonomous nervous system in the effects of sub-daily PM exposures has also been suggested by studies on cardiac repolarisation (not reviewed here): an increase in QTC interval and a decrease in T-wave amplitude with exposure to sub-daily levels of PM have both been reported [55, 57]. Nonetheless, further studies are needed to clarify the pathological implications, the prognostic value of a short-term decrease in heart rate variability (HRV) [61]. Furthermore, considerations are also needed to better understand if a decrease in HRV is an indicator of an alteration of the sympathetic tone. Further reviews should look at other HRV time and frequency domain parameters than SDNN.

Other physiological mechanisms, such as vasomotor dysfunction, are also likely implicated in the acute cardiovascular effects of sub-daily exposure to PM but discrepancies remain. For instance, associations between these exposures and FBF were found for both short lags (<4 h) and long lags (24 h) but no associations were found for lags of 6 to 8 h [10, 43]. While vasomotor dysfunction does seem to be involved in the cardiac pathophysiology of PM exposure, so far it is unlikely to underlie effects such as ischemia, occurring during or immediately after exposure (e.g. [10]) because of differences in lags between exposure and onset of changes between the two. It is possible that vasomotor dysfunction may be involved in effects occurring hours after exposure, perhaps following the release of inflammatory mediators.

We performed a non-meta-analytical systematic literature review of studies that assessed a number of selected cardiovascular effects and physiological measures. Our literature review was framed by a theoretical model (presented in Figure 1) and, our quantitative assessment of the evidence was limited to counting studies presenting statistically significant associations. We recognize the limitations of our approach to identify the presence of an association which was based on statistical significance. We also recognize the limitations of our evaluation of the evidence of an effect as either 'suggestive' or 'limited', which was based on the number of studies with significant effects versus non-significant effects (i.e. suggestive if more than half of the studies showed a statistically significant association in the same direction). Our approach to assess the evidence may be biased by the tendency to publish positive results. Furthermore, issues of design and power may have limited our ability to report real associations. However, we consider our approach reasonable as most epidemiological studies reviewed used a longitudinal design with numerous repeated measure and thus, high power. Furthermore, while the present assessment does not allow the quantification of effects, our mechanistic framework does allow consideration of both human experimental and epidemiological studies in assessing the cardiovascular effects of exposure to sub-daily PM exposures and identifies research gaps. Future systematic reviews, mainly assessing the mechanistic basis of sudden cardiovascular effects, should consider including studies that assess physiological measures not included in this analysis, such as markers of systemic inflammation (e.g. C-reactive protein) and other indicators of vasoconstriction or vasoconstriction agonists (e.g. endothelin).

Based on our assessment of the literature, it appears that further studies are needed to confirm that sub-daily exposure to PM is associated with MI and ischemia as well as to address the influence of the size and the composition of the PM. Additionally, the literature reviewed does not provide any clear tendency as to the effects of different concentrations of exposure: epidemiological studies using linear models did not provide an exposure effect threshold. More work is needed to characterise the dose-response relationships. Studies should also address whether the observed effects of sub-daily exposures to PM are due to other concurrent air pollutants or to the combined action of a number of contaminants. Indeed while in the epidemiological studies we reviewed subjects were exposed to mixtures of ambient air pollutants, in a number of experimental studies showing associations exposure was often to either diesel exhaust (itself a pollutant mixture) or to CAP (concentrated ambient particles). Furthermore, exposure assessment in environmental epidemiological studies, as opposed to the highly controlled human experimental studies, can only be observational and as such is imperfect in assessing true subject exposures especially in cases where central pollution monitoring station data is used. Whether or not this limitation is more of concern in epidemiological studies with shorter sub-daily exposure assessment rather than longer averaged exposures is not clear. Another issue that deserves consideration is the influence of smoking on the health response to PM. In most studies so far, smokers were excluded or, the effect of smoking was adjusted statistically (data not shown).

The physiological mechanisms underlying the associations between sub-daily exposure to PM and MI or ischemia need to be clarified. For instance, experimental studies can be designed to better understand the time course of such effects. It is difficult to sort out the time course of effects with epidemiological studies as exposure has usually not been instantaneous. The influence of pre-existing cardiovascular diseases and medication use, on the effects of sub-daily exposure to PM, also need to be determined.

Finally, studies are needed to clarify if cardiovascular effects of sub-daily exposure to PM are captured by daily exposure. To date only daily levels of PM are subjected to regulation whereas sub-daily exposures of PM are not regulated. Information on this issue may be provided by time-series studies, in assessing the association between both daily mean PM levels and, hourly levels, with daily deaths or emergency room visits for cardiovascular effects. To our knowledge, very few studies (e.g. [56]) have assessed this so far, even with the limited effort that it would require.

Conclusions

Future studies should clarify the points discussed above, specifically to which PM size fraction, composition and concurrent pollutants on sub-daily exposure, the cardiovascular effects are associated and by what mechanisms. It is questionable whether obtaining sufficiently precise information on these determinants is feasible with data from central pollution monitoring stations as opposed to personal monitors or an experimental study design. Although studies are needed to strengthen the evidence, our assessment of the literature on the effects of sub-daily exposure to PM leads to the conclusion that exposures of under 6 hours (including exposure as short as 30 to 60 minutes) may be associated with the occurrence of cardiovascular effects such as ischemia and MI possibly in the elderly and in individuals with prior cardiovascular diseases. Given that exposure to sub-daily high levels of PM (for a few hours) is frequent, we recommend that those with cardiovascular diseases avoid such situations.

Abbreviations

BAD: 

Brachial artery diameter

BP: 

Blood pressure

CAP: 

Concentrated Ambient Particles

FBF: 

Forearm blood flow measured by plethysmography

FMD: 

Flow mediated diameter

HRV: 

Heart rate variability

MI: 

Myocardial infarction

PM: 

Fine particles

SDNN: 

Standard deviation of all the normal-to-normal intervals

t-PA Ag: 

Tissue plasminogen activator antigen

Declarations

Acknowledgements

This project was supported by funding from The Canadian National Collaborating Center for Environmental Health (NCCEH).

Authors’ Affiliations

(1)
Département de santé environnementale et santé au travail, Université de Montréal
(2)
Institut National de Santé Publique du Québec (INSPQ)
(3)
Direction de Santé Publique de l'Agence de la Santé et des Services Sociaux de Montréal
(4)
British Columbia Center for Disease Control

References

  1. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC, Tager I, Expert Panel on Population and Prevention Science of the American Heart Association: Air pollution and cardiovascular diseases: A statement for health care professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004, 190: 2655-2671. 10.1161/01.CIR.0000128587.30041.C8.View ArticleGoogle Scholar
  2. U.S. Environmental Protection Agency: Air Quality Criteria for Particulate matter. Washington, DC. 2004Google Scholar
  3. Mills NL, Törnqvist H, Robinson SD, Gonzalez MC, Söderberg S, Sandström T, Blomberg A, Newby DE, Donaldson K: Air pollution and atherothrombosis. Inhal Toxicol. 2007, 19: 81-89. 10.1080/08958370701495170.View ArticleGoogle Scholar
  4. Becker BJ: Examining theoretical models through research synthesis. The benefits of model-driven meta-analysis. Eval Health Prof. 2001, 24: 190-217. 10.1177/01632780122034876.View ArticleGoogle Scholar
  5. Cooper H, Hedges LV: The handbook of research synthesis. 1994, NY: Russell Sage FoundationGoogle Scholar
  6. Chuang KJ, Coull BA, Zanobetti A, Suh H, Schwartz J, Stone PH, Litonjua A, Speizer FE, Gold DR: Particulate air pollution as a risk factor for ST-segment depression in patients with coronary artery disease. Circulation. 2008, 118: 1314-1320. 10.1161/CIRCULATIONAHA.108.765669.View ArticleGoogle Scholar
  7. Gold DR, Litonjua AA, Zanobetti A, Coull BA, Schwartz J, MacCallum G, Verrier RL, Nearing BD, Canner MJ, Suh H, Stone PH: Air pollution and ST-segment depression in elderly subjects. Environ Health Perspect. 2005, 113: 883-887. 10.1289/ehp.7737.View ArticleGoogle Scholar
  8. Lanki T, Hoek G, Timonen KL, Peters A, Tiittanen P, Vanninen E, Pekkanen J: Hourly variation in fine particle exposure is associated with transiently increased risk of ST segment depression. Occup Environ Med. 2008, 65: 782-786. 10.1136/oem.2007.037531.View ArticleGoogle Scholar
  9. Gong H, Linn WS, Sioutas C, Terrell SL, Clark KW, Anderson KR, Terrell LL: Controlled Exposures of Healthy and Asthmatic Volunteers to Concentrated Ambient Fine Particles in Los Angeles'. Inhal Toxicol. 2003, 15: 305-325. 10.1080/08958370304455.View ArticleGoogle Scholar
  10. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE: Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. New Engl J Med. 2007, 357: 1075-1082. 10.1056/NEJMoa066314.View ArticleGoogle Scholar
  11. Ljungman PL, Berglind N, Holmgren C, Gadler F, Edvardsson N, Pershagen G, Rosenqvist M, Sjögren B, Bellander T: Rapid effects of air pollution on ventricular arrhythmias. Eur Heart J. 2008, 29: 2894-2901. 10.1093/eurheartj/ehn463.View ArticleGoogle Scholar
  12. Rich DQ, Mittleman MA, Link MS, Schwartz J, Luttmann-Gibson H, Catalano PJ, Speizer FE, Gold DR, Dockery DW: Increased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution. Environ Health Perspect. 2006, 114: 120-123. 10.1289/ehp.8371.View ArticleGoogle Scholar
  13. Rich DQ, Kim MH, Turner JR, Mittleman MA, Schwartz J, Catalano PJ, Dockery DW: Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air pollutants in the St Louis, Missouri metropolitan area. Occup Environ Med. 2006, 63: 591-596. 10.1136/oem.2005.023457.View ArticleGoogle Scholar
  14. Rich DQ, Schwartz J, Mittleman MA, Link M, Luttmann-Gibson H, Catalano PJ, Speizer FE, Dockery DW: Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am J Epidemiol. 2005, 161: 1123-1132. 10.1093/aje/kwi143.View ArticleGoogle Scholar
  15. Gong H, Linn WS, Clark KW, Anderson KR, Sioutas C, Alexis NE, Cascio WE, Devlin RB: Exposures of healthy and asthmatic volunteers to concentrated ambient ultrafine particles in Los Angeles. Inhal Toxicol. 2008, 20: 533-545. 10.1080/08958370801911340.View ArticleGoogle Scholar
  16. Gong H, Linn WS, Terrell SL, Clark KW, Geller MD, Anderson KR, Cascio WE, Sioutas C: Altered heart-rate variability in asthmatic and healthy volunteers exposed to concentrated ambient coarse particles. Inhal Toxicol. 2004, 16: 335-343. 10.1080/08958370490439470.View ArticleGoogle Scholar
  17. Gong H, Linn WS, Terrell SL, Anderson KR, Clark KW, Sioutas C, Cascio WE, Alexis N, Devlin RB: Exposures of elderly volunteers with and without chronic obstructive pulmonary disease (COPD) to concentrated ambient fine particulate pollution. Inhal Toxicol. 2004, 16: 731-744. 10.1080/08958370490499906.View ArticleGoogle Scholar
  18. Murakami Y, Ono M: Myocardial infarction deaths after high level exposure to particulate matter. J Epidemiol Commun Health. 2006, 60: 262-266. 10.1136/jech.2005.038315.View ArticleGoogle Scholar
  19. Peters A, von Klot S, Heier M, Trentinaglia I, Cyrys J, Hörmann A, Hauptmann M, Wichmann HE, Löwel H: Particulate air pollution and nonfatal cardiac events. Part I. Air pollution, personal activities, and onset of myocardial infarction in a case-crossover study. Res Rep Health Eff Inst. 2005, 124: 1-66. discussion 67-82, 141-148Google Scholar
  20. Peters A, Dockery DW, Muller JE, Mittleman MA: Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001, 103: 2810-2815.View ArticleGoogle Scholar
  21. Rosenthal FS, Carney JP, Olinger ML: Out-of-hospital cardiac arrest and airborne fine particulate matter: a case-crossover analysis of emergency medical services data in Indianapolis, Indiana. Environ Health Perspect. 2008, 116: 631-536. 10.1289/ehp.10757.View ArticleGoogle Scholar
  22. Sullivan J, Sheppard L, Schreuder A, Ishikawa N, Siscovick D, Kaufman J: Relation between short-term fine-particulate matter exposure and onset of myocardial infarction. Epidemiology. 2005, 16: 41-48. 10.1097/01.ede.0000147116.34813.56.View ArticleGoogle Scholar
  23. Adar SD, Gold DR, Coull BA, Schwartz J, Stone PH, Suh H: Focused exposures to airborne traffic particles and heart rate variability in the elderly. Epidemiology. 2007, 18: 95-103. 10.1097/01.ede.0000249409.81050.46.View ArticleGoogle Scholar
  24. Chang LT, Tang CS, Pan YZ, Chan CC: Association of heart rate variability of the elderly with personal exposure to PM 1, PM 1-2.5, and PM 2.5-10. B Environ Contam Tox. 2007, 79: 552-556. 10.1007/s00128-007-9233-4.View ArticleGoogle Scholar
  25. Chuang KJ, Chan CC, Su TC, Lin LY, Lee CT: Associations between particulate sulfate and organic carbon exposures and heart rate variability in patients with or at risk for cardiovascular diseases. J Occup Environ Med. 2007, 49: 610-617. 10.1097/JOM.0b013e318058205b.View ArticleGoogle Scholar
  26. Chuang KJ, Chan CC, Chen NT, Su TC, Lin LY: Effects of particle size fractions on reducing heart rate variability in cardiac and hypertensive patients. Environ Health Perspect. 2005, 113: 1693-1697. 10.1289/ehp.8145.View ArticleGoogle Scholar
  27. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R: Ambient pollution and heart rate variability. Circulation. 2000, 101: 1267-1273.View ArticleGoogle Scholar
  28. Lipsett MJ, Tsai FC, Roger L, Woo M, Ostro BD: Coarse particles and heart rate variability among older adults with coronary artery disease in the Coachella Valley, California. Environ Health Perspect. 2006, 114: 1215-1220. 10.1289/ehp.8856.View ArticleGoogle Scholar
  29. Magari SR, Schwartz J, Williams PL, Hauser R, Smith TJ, Christiani DC: The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology. 2002, 13: 305-310. 10.1097/00001648-200205000-00011.View ArticleGoogle Scholar
  30. Luttmann-Gibson H, Suh HH, Coull BA, Dockery DW, Sarnat SE, Schwartz J, Stone PH, Gold DR: Short-term effects of air pollution on heart rate variability in senior adults in Steubenville, Ohio. J Occup Environ Med. 2006, 48: 780-788. 10.1097/01.jom.0000229781.27181.7d.View ArticleGoogle Scholar
  31. Sullivan JH, Schreuder AB, Trenga CA, Liu SLJ, Larson TV, Koenig JQ, Kaufman JD: Association between short term exposure to fine particulate matter and heart rate variability in older subjects with and without heart disease. Thorax. 2005, 60: 462-466. 10.1136/thx.2004.027532.View ArticleGoogle Scholar
  32. Vallejo M, Ruiz S, Hermosillo AG, Borja-Aburto VH, Cardenas M: Ambient fine particles modify heart rate variability in young healthy adults. J Exp Sci Environ Epidemiol. 2006, 16: 125-130. 10.1038/sj.jea.7500447.View ArticleGoogle Scholar
  33. Wheeler A, Zanobetti A, Gold DR, Schwartz J, Stone P, Suh HH: The relationship between ambient air pollution and heart rate variability differs for individuals with heart and pulmonary disease. Environ Health Perspect. 2006, 114: 560-566. 10.1289/ehp.8337.View ArticleGoogle Scholar
  34. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, Huang LS, Cox C, Zareba W, Oberdörster G: Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med. 2005, 171: 1129-1135. 10.1164/rccm.200406-837OC.View ArticleGoogle Scholar
  35. Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W: Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability. Eur Respir J Suppl. 2003, 40: 76s-80s. 10.1183/09031936.03.00402403.View ArticleGoogle Scholar
  36. Frampton MW, Utell MJ, Zareba W, Oberdorster G, Cox C, Huang LS, Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM, Stewart J: Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst. 2004, 126: 1-47. discussion 49-63Google Scholar
  37. Peretz A, Kaufman JD, Trenga CA, Allen J, Carlsten C, Aulet MR, Adar SD, Sullivan JH: Effects of diesel exhaust inhalation on heart rate variability in human volunteers. Environ Res. 2008, 107: 178-184. 10.1016/j.envres.2008.01.012.View ArticleGoogle Scholar
  38. Routledge HC, Manney S, Harrison RM, Ayres JG, Townend JN: Effect of inhaled sulphur dioxide and carbon particles on heart rate variability and markers of inflammation and coagulation in human subjects. Heart. 2006, 92: 220-227. 10.1136/hrt.2004.051672.View ArticleGoogle Scholar
  39. Scharrer E, Hessel H, Kronseder A, Guth W, Rolinski B, Jorres RA, Radon K, Schierl R, Angerer P, Nowak D: Heart rate variability, hemostatic and acute inflammatory blood parameters in healthy adults after short-term exposure to welding fume. Int Arch Occup Environ Health. 2007, 80: 265-272. 10.1007/s00420-006-0127-2.View ArticleGoogle Scholar
  40. Harrabi I, Rondeau V, Dartigues JF, Tessier J-F, Filleul L: Effects of particulate air pollution on systolic blood pressure: A population-based approach. Environ Res. 2006, 101: 89-93. 10.1016/j.envres.2006.01.012.View ArticleGoogle Scholar
  41. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F: Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002, 105: 1534-1536. 10.1161/01.CIR.0000013838.94747.64.View ArticleGoogle Scholar
  42. Dales R, Liu L, Szyszkowicz M, Dalipaj M, Willey J, Kulka R, Ruddy TD: Particulate air pollution and vascular reactivity: the bus stop study. Int Arch Occup Environ Health. 2007, 81: 159-64. 10.1007/s00420-007-0199-7.View ArticleGoogle Scholar
  43. Mills NL, Robinson SD, Fokkens PH, Leseman DL, Miller MR, Anderson D, Freney EJ, Heal MR, Donovan RJ, Blomberg A, Sandstrom T, MacNee W, Boon NA, Donaldson K, Newby DE, Cassee FR: Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ Health Perspect. 2008, 116: 709-715. 10.1289/ehp.11016.View ArticleGoogle Scholar
  44. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE: Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005, 112: 3930-3936. 10.1161/CIRCULATIONAHA.105.588962.View ArticleGoogle Scholar
  45. Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, Carlsten C, Wilkinson CW, Gill EA, Kaufman JD: Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ Health Perspect. 2008, 116: 937-942. 10.1289/ehp.11027.View ArticleGoogle Scholar
  46. Rundell KW, Hoffman JR, Caviston R, Bulbulian R, Hollenbach AM: Inhalation of ultrafine and fine particulate matter disrupts systemic vascular function. Inhal Toxicol. 2007, 19: 133-140. 10.1080/08958370601051727.View ArticleGoogle Scholar
  47. Shah AP, Pietropaoli AP, Frasier LM, Speers DM, Chalupa DC, Delehanty JM, Huang LS, Utell MJ, Frampton MW: Effect of inhaled carbon ultrafine particles on reactive hyperemia in healthy human subjects. Environ Health Perspect. 2008, 116: 375-380. 10.1289/ehp.10323.View ArticleGoogle Scholar
  48. Törnqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL, Macnee W, Donaldson K, Soderberg S, Newby DE, Sandstrom T, Blomberg A: Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med. 2007, 176: 395-400. 10.1164/rccm.200606-872OC.View ArticleGoogle Scholar
  49. Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, Brook RD: Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect. 2005, 113: 1052-1055. 10.1289/ehp.7785.View ArticleGoogle Scholar
  50. Rückerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T, Berglind N, Chrysohoou C, Forastiere F, Jacquemin B, von Klot S, Koenig W, Küchenhoff H, Lanki T, Pekkanen J, Perucci CA, Schneider A, Sunyer J, Peters A, AIRGENE Study Group: Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect. 2007, 115: 1072-1080. 10.1289/ehp.10021.View ArticleGoogle Scholar
  51. Carlsten C, Kaufman JD, Peretz A, Trenga CA, Sheppard L, Sullivan JH: Coagulation markers in healthy human subjects exposed to diesel exhaust. Thromb Res. 2007, 120: 849-855. 10.1016/j.thromres.2007.01.005.View ArticleGoogle Scholar
  52. Ghio AJ, Kim C, Devlin RB: Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med. 2000, 162: 981-988.View ArticleGoogle Scholar
  53. Lucking AJ, Lundback M, Mills NL, Faratian D, Barath SL, Pourazar J, Cassee FR, Donaldson K, Boon NA, Badimon JJ, Sandstrom T, Blomberg A, Newby DE: Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J. 2008, 29: 3043-3051. 10.1093/eurheartj/ehn464.View ArticleGoogle Scholar
  54. Salvi S, Blomberg A, Rudell B, Kelly F, Sandstrom T, Holgate ST, Frew A: Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med. 1999, 159: 702-709.View ArticleGoogle Scholar
  55. Henneberger A, Zareba W, Ibald-Mulli A, Ruckerl R, Cyrys J, Couderc JP, Mykins B, Woelke G, Wichmann HE, Peters A: Repolarization changes induced by air pollution in ischemic heart disease patients. Environ Health Persectp. 2005, 113: 440-446. 10.1289/ehp.7579.View ArticleGoogle Scholar
  56. Morgan G, Corbett S, Wlodarczyk J: Air pollution and hospital admissions in Sydney, Australia, 1990 to 1994. Am J Public Health. 1998, 88: 1761-1766. 10.2105/AJPH.88.12.1761.View ArticleGoogle Scholar
  57. Yue W, Schneider A, Stolzel M, Ruckerl R, Cyrys J, Pan X, Zareba W, Koenig W, Wichmann HE, Peters A: Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients. Mutat Res. 2007, 621: 50-60.View ArticleGoogle Scholar
  58. Fang SC, Cavallari JM, Eisen EA, Chen JC, Mittleman MA, Christiani DC: Vascular function, inflammation, and variations in cardiac autonomic responses to particulate matter among welders. Am J Epidemiol. 2009, 169: 848-856. 10.1093/aje/kwn405.View ArticleGoogle Scholar
  59. Riediker M, Cascio WE, Griggs TR, Herbst MC, Bromberg PA, Neas L, Williams RW, Devlin RB: Particulate matter exposure in cars is associated with cardiovascular effects in healthy young men. Am J Respir Crit Care. 2004, 169: 934-940. 10.1164/rccm.200310-1463OC.View ArticleGoogle Scholar
  60. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC: Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation. 2001, 104: 986-991. 10.1161/hc3401.095038.View ArticleGoogle Scholar
  61. Towend JN: The way to dusty death?. Thorax. 2005, 60: 441-442. 10.1136/thx.2004.037903.View ArticleGoogle Scholar

Copyright

© Burgan et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement